【レポートの概要（一部）】
TABLE OF CONTENTS
1 INTRODUCTION 23
1.1 OBJECTIVES OF THE STUDY 23
1.2 MARKET DEFINITION 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 YEARS CONSIDERED FOR THE STUDY 27
1.4 CURRENCY 27
1.5 STAKEHOLDERS 27
2 RESEARCH METHODOLOGY 28
2.1 RESEARCH DATA 28
2.1.1 SECONDARY DATA 28
2.1.1.1 Key data from secondary sources 29
2.1.1 PRIMARY DATA 29
2.1.1.1 Breakdown of primaries 30
2.1.1.2 Key data from primary sources 30
2.1.1.3 Key industry insights 31
2.2 MARKET SIZE ESTIMATION 31
2.2.1.1 Bottom-up approach 32
2.2.1.2 Top-down approach 32
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 33
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 35
2.4.1 ASSUMPTIONS 35
2.4.2 LIMITATIONS 35
3 EXECUTIVE SUMMARY 36
3.1 INTRODUCTION 36
3.2 CURRENT SCENARIO 37
3.3 FUTURE OUTLOOK 38
3.4 CONCLUSION 40
4 PREMIUM INSIGHTS 41
4.1 ATTRACTIVE OPPORTUNITIES IN THE LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET 41
4.2 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET GROWTH RATE, BY TECHNOLOGY AND REGION (2014–2019) 42
4.3 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY AND REGION, 2014 ($MILLION) 43
4.4 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY, 2012–2019 ($MILLION) 44
5 MARKET OVERVIEW 45
5.1 INTRODUCTION 46
5.2 MARKET SEGMENTATION 46
5.2.1 BY TECHNOLOGY 47
5.2.2 BY END USER 47
5.3 MARKET DYNAMICS 48
5.3.1 DRIVERS 49
5.3.1.1 Increasing government spending on pharmaceutical R&D in emerging nations 49
5.3.1.2 Growing food safety concerns 50
5.3.1.3 Technological advancements in analytical devices 50
5.3.1.4 Funding sources increase the purchasing power of major research institutions 51
5.3.2 RESTRAINTS 52
5.3.2.1 High cost of instruments 52
5.3.2.2 Presence of alternative technologies 52
5.3.3 OPPORTUNITIES 53
5.3.3.1 Emerging markets offering lucrative growth opportunities 53
5.3.3.2 Growing proteomics market 53
5.3.3.3 Growing environmental safety concerns 54
5.3.3.4 Increasing demand from applied markets 55
5.3.3.5 Opportunity for lab automation solutions in biobank applications 55
5.3.4 CHALLENGES 56
5.3.4.1 Extensive requirements in developing chromatography systems that generate pressures of above 20,000 psi 56
5.3.4.2 Survival of small players in the lab automation market 56
5.3.4.3 Adoption and implementation of MIQE guidelines for publishing qPCR- and dPCR–based research 56
6 INDUSTRY INSIGHTS 57
6.1 INTRODUCTION 57
6.2 VALUE CHAIN ANALYSIS 57
6.3 INDUSTRY TRENDS 58
6.3.1 RISING FOCUS OF MARKET PLAYERS TOWARDS THE DEVELOPMENT OF MINIATURIZED INSTRUMENTS 58
6.3.2 INCREASING ADOPTION OF HYPHENATED TECHNOLOGIES 58
6.3.3 TIE-UPS BETWEEN ANALYTICAL INSTRUMENT MANUFACTURERS AND RESEARCH LABORATORIES/ACADEMIC INSTITUTIONS 59
6.4 PORTER’S FIVE FORCES ANALYSIS 59
6.4.1 THREAT OF NEW ENTRANTS 60
6.4.2 THREAT FROM SUBSTITUTES 61
6.4.3 BARGAINING POWER OF SUPPLIERS 61
6.4.4 BARGAINING POWER OF BUYERS 61
6.4.5 INTENSITY OF COMPETITIVE RIVALRY 62
7 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY TECHNOLOGY 63
7.1 INTRODUCTION 64
7.2 CHROMATOGRAPHY 65
7.2.1 DRIVERS 66
7.2.1.1 New international GMP & GDP certification for pharmaceutical excipients (North America & Europe): EXCiPACT 66
7.2.1.2 Industry support to research laboratories and academic institutes 67
7.2.1.3 Rise in government investments in chromatography technologies 67
7.2.1.4 Increased importance of chromatography tests in drug approvals 67
7.2.2 RESTRAINT 68
7.2.2.1 High cost of instruments 68
7.2.3 CHALLENGE 68
7.2.3.1 Obtaining identical results from UHPLC after transfer of HPLC to UHPLC 68
7.2.4 CHROMATOGRAPHY MARKET, BY TYPE 69
7.2.4.1 Liquid chromatography 69
7.2.4.2 Gas chromatography 70
7.2.4.3 Other chromatography techniques 71
7.2.5 MARKET SHARE ANALYSIS, BY KEY PLAYER 72
7.3 ELECTROPHORESIS 72
7.3.1 DRIVERS 74
7.3.1.1 Preferred technique for fragile molecules and variants 74
7.3.1.2 Increase in demand for 2D gel electrophoresis 74
7.3.1.3 Lab-on-a-Chip (LOC) technology 74
7.3.2 RESTRAINT 74
7.3.2.1 Alternative technologies provide better results 74
7.3.3 ELECTROPHORESIS MARKET, BY TYPE 75
7.3.3.1 Gel electrophoresis 75
7.3.3.2 Capillary electrophoresis 75
7.4 DNA SEQUENCERS & AMPLIFIERS 76
7.4.1 DRIVERS 77
7.4.1.1 Technological advancements 77
7.4.1.2 Increasing public and private investments, funds, and grants 78
7.4.1.3 Rising incidence of infectious diseases and genetic disorders 78
7.4.2 RESTRAINTS 79
7.4.2.1 High cost of equipment 79
7.4.3 DNA SEQUENCERS & AMPLIFIERS MARKET, BY TYPE 80
7.4.3.1 DNA sequencers 80
7.4.3.1.1 Market share analysis, by key player 81
7.4.3.2 DNA amplifiers 81
7.4.3.2.1 Thermal Cyclers 82
7.4.3.2.2 Real-time PCR 83
7.4.3.2.3 Others 83
7.5 LAB AUTOMATION 84
7.5.1 DRIVERS 86
7.5.1.1 Process miniaturization leading to low reagent cost and high productivity 86
7.5.1.2 Progress in drug discovery and clinical diagnostics 86
7.5.1.3 Large workforce demand and supply gap 87
7.5.1.4 Greater productivity and reduction in costs 87
7.5.1.5 Smaller volumes of samples and reagents required 87
7.5.2 RESTRAINTS 87
7.5.2.1 Automation not a priority for small- and medium-sized labs 87
7.5.2.2 Indefinite data interchange/communication standards 87
7.5.3 LAB AUTOMATION MARKET, BY TYPE 88
7.5.3.1 Automatic liquid handling 88
7.5.3.2 Microplate readers 88
7.5.3.3 Standalone robots 89
7.5.3.4 Automated storage and retrieval systems 90
7.5.3.5 Software and informatics 90
7.5.3.6 Others 92
7.5.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 93
7.6 SPECTROSCOPY 93
7.6.1 DRIVERS 95
7.6.1.1 Global alliances amongst leading research institutes to boost drug discovery 95
7.6.1.2 Atomic absorption spectroscopy to aid in the drug safety process 95
7.6.1.3 Increasing life science R&D spending 95
7.6.2 RESTRAINTS 96
7.6.2.1 High costs restrict purchase 96
7.6.2.2 Need for skilled professionals 96
7.6.3 SPECTROSCOPY MARKET, BY TYPE 96
7.6.3.1 Molecular spectroscopy 96
7.6.3.1.1 Market share analysis, by key player 97
7.6.3.2 Atomic spectroscopy 97
7.6.3.2.1 Market share analysis, by key player 98
7.6.3.3 Mass spectrometry 99
7.6.3.3.1 Market share analysis, by key player 99
7.7 IMMUNOASSAY 100
7.7.1 DRIVERS 102
7.7.1.1 Rising incidence of chronic and infectious diseases in emerging economies 102
7.7.1.2 Increasing number of approvals for immunoassay techniques 104
7.7.1.3 Advantages such as high sensitivity, low cost, and faster turnaround times 104
7.7.1.4 Increasing health awareness 105
7.7.2 RESTRAINTS 105
7.7.2.1 Low detection restricts adoption of immunoassay tests 105
7.7.2.2 Pricing pressure for some tests due to competition from lower cost-per-test technologies 105
7.7.3 IMMUNOASSAY MARKET, BY TYPE 105
7.7.3.1 Enzyme immunoassay (EIA) 105
7.7.3.2 Fluorescence immunoassay (FIA) 106
7.7.3.3 Chemiluminescence immunoassay (CLIA) 107
7.7.3.4 Radioimmunoassay (RIA) 107
7.7.3.5 Others 108
7.7.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 109
7.8 MICROARRAY 110
7.8.1 DRIVERS AND OPPORTUNITIES 111
7.8.1.1 Growth in personalized medicine 111
7.8.1.2 Technological advances 111
7.8.1.3 Increasing application areas 111
7.8.2 RESTRAINT 112
7.8.2.1 Lack of technical know-how 112
7.8.3 MICROARRAYS MARKET, BY TYPE 112
7.8.3.1 DNA microarrays 112
7.8.3.2 Protein microarrays 112
7.8.3.3 Tissue microarrays 113
7.8.3.4 Cell microarrays 113
7.9 FLOW CYTOMETRY 114
7.9.1 DRIVERS 116
7.9.1.1 Technological advancements in flow cytometry instruments 116
7.9.1.2 Fostering use of flow cytometry techniques in research activities 116
7.9.1.3 Increasing use of flow cytometry in clinical trials 117
7.9.1.4 Increasing use of flow cytometry in HIV and cancer research 117
7.9.1.5 Launch of new reagents for specific applications like diagnostics and drug discovery 117
7.9.2 RESTRAINTS 118
7.9.2.1 High cost of instruments 118
7.9.2.2 Reluctance among researchers in emerging countries to use flow cytometry 118
7.9.2.3 Lack of awareness and dearth of training 118
7.9.3 FLOW CYTOMETRY MARKET, BY TYPE 118
7.9.3.1 Cell-based flow cytometry 118
7.9.3.2 Bead-based flow cytometry 119
7.9.3.3 Others 120
7.9.4 MARKET SHARE ANALYSIS, BY KEY PLAYER 121
7.10 OTHER INSTRUMENTS 121
7.10.1 CENTRIFUGES 122
7.10.2 LABORATORY BALANCES 123
7.10.2.1 Driver 123
7.10.2.1.1 Technological advancements in laboratory balances 123
7.10.2.2 Challenge 123
7.10.2.2.1 Effect of environmental disturbances 123
7.10.3 INCUBATORS 124
7.10.3.1 Drivers 124
7.10.3.1.1 Genetic engineering will drive the market 124
7.10.3.1.2 Stem cells and biological therapeutics increase the demand for CO2 incubators 124
7.10.3.2 Challenge 124
7.10.3.2.1 Contamination – A Major Concern 124
7.10.4 FUME HOODS 125
7.10.4.1 Driver 125
7.10.4.1.1 Improvements in device structure 125
7.10.4.2 Restraint 125
7.10.4.2.1 High electricity consumption 125
8 LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET, BY END USER 126
8.1 INTRODUCTION 127
8.2 CHROMATOGRAPHY 127
8.2.1 PHARMACEUTICAL COMPANIES AND CROS 129
8.2.2 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES 129
8.2.3 ACADEMIC RESEARCH LABORATORIES 130
8.2.4 AGRICULTURE & FOOD INDUSTRY 131
8.2.5 ENVIRONMENTAL TESTING 131
8.2.6 OTHERS 132
8.3 ELECTROPHORESIS 132
8.3.1 PHARMACEUTICAL COMPANIES AND CROS 133
8.3.2 BIOTECHNOLOGY COMPANIES AND LIFE SCIENCE RESEARCH INSTITUTIONS 133
8.3.3 FORENSIC SCIENCE AND CLINICAL DIAGNOSTIC LABORATORIES 134
8.3.4 ACADEMIC INSTITUTIONS 134
8.3.5 OTHERS 134
8.4 DNA SEQUENCERS & AMPLIFIERS 135
8.4.1 PHARMA & BIOTECH COMPANIES AND CROS 136
8.4.2 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES 136
8.4.3 HOSPITALS AND DIAGNOSTIC CENTERS 137
8.4.4 FORENSIC SCIENCE LABORATORIES 137
8.5 LAB AUTOMATION 137
8.5.1 PHARMA & BIOTECH COMPANIES AND CROS 139
8.5.2 HOSPITALS AND PRIVATE LABS 139
8.5.3 RESEARCH INSTITUTIONS 140
8.5.4 ACADEMIC INSTITUTIONS 140
8.6 SPECTROSCOPY 140
8.6.1 PHARMACEUTICAL COMPANIES AND CROS 142
8.6.2 BIOTECHNOLOGY AND BIOPHARMACEUTICAL COMPANIES 142
8.6.3 ENVIRONMENTAL TESTING 143
8.6.4 FOOD AND BEVERAGE INDUSTRY 143
8.6.5 INDUSTRIAL CHEMISTRY 144
8.6.6 ACADEMIC INSTITUTIONS 144
8.6.7 OTHERS 145
8.7 IMMUNOASSAYS 145
8.7.1 HOSPITALS (PRIVATE/PUBLIC) 146
8.7.2 LABORATORIES (PRIVATE/PUBLIC) 146
8.7.3 PHARMACEUTICAL & BIOTECH COMPANIES AND CROS 147
8.7.4 ACADEMIC INSTITUTIONS 147
8.7.5 OTHERS 147
8.8 MICROARRAYS 148
8.8.1 PHARMACEUTICAL AND BIOPHARMACEUTICAL INDUSTRY 149
8.8.2 RESEARCH LABORATORIES 149
8.8.3 DIAGNOSTIC LABORATORIES 149
8.8.4 ACADEMIC INSTITUTIONS 150
8.8.5 OTHERS 150
8.9 FLOW CYTOMETRY 150
8.9.1 COMMERCIAL ORGANIZATIONS 151
8.9.2 ACADEMIC INSTITUTIONS 151
8.9.3 HOSPITALS 152
8.9.4 CLINICAL TESTING LABS 152
8.9.5 MEDICAL SCHOOLS 153
8.10 OTHER INSTRUMENTATION 154
8.10.1 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES AND CROS 154
8.10.2 RESEARCH LABORATORIES 154
8.10.3 ACADEMIC INSTITUTIONS 154
8.10.4 OTHERS 154
9 GLOBAL LIFE SCIENCE AND CHEMICAL INSTRUMENTATION MARKET,
BY REGION 155
9.1 INTRODUCTION 156
9.2 NORTH AMERICA 158
9.2.1 FUNDING IN MEDICAL RESEARCH MAY DEVELOP NEW APPLICATION AREAS FOR ANALYTICAL TECHNOLOGIES 159
9.2.2 DRUG DEVELOPMENT REGULATIONS IN NORTH AMERICA 159
9.2.3 GROWING METABOLOMICS RESEARCH IN THE U.S. 160
9.2.4 CONFERENCES, DISCUSSIONS, SYMPOSIUMS, & SEMINARS 160
9.2.5 RISING PREVALENCE OF CHRONIC DISEASES AND AGING POPULATION 161
9.3 EUROPE 166
9.3.1 DIRECT AND INDIRECT FINANCIAL INVESTMENTS IN ANALYTICAL INSTRUMENTS 167
9.3.2 STRATEGIC ALLIANCES IN EUROPE TO TRIGGER THE GROWTH OF DRUG DISCOVERY 167
9.3.3 BURGEONING GROWTH OF THE EUROPEAN BIOSIMILARS MARKET 168
9.3.4 CONFERENCES AND SYMPOSIA 168
9.3.5 DEVELOPING PHARMACEUTICAL SECTOR IN RUSSIA 168
9.4 ASIA-PACIFIC 173
9.4.1 STRATEGIC EXPANSIONS BY KEY MARKET PLAYERS IN EMERGING ASIAN COUNTRIES 174
9.4.2 GROWING PHARMACEUTICAL INDUSTRY IN INDIA AND CHINA 174
9.4.3 EXTENSIVE CROP RESEARCH IN ASIA 175
9.4.4 GOVERNMENT INVESTMENTS IN THE BIOMEDICAL INDUSTRY IN CHINA 175
9.4.5 INFRASTRUCTURAL DEVELOPMENT IN VIETNAM 175
9.4.6 SINGAPORE, AN IMPORTANT MARKET FOR LIFE SCIENCE AND CHEMICAL INSTRUMENTATION 176
9.4.7 CONFERENCES, EXHIBITIONS, & MEETINGS ON ANALYTICAL INSTRUMENTS 176
9.5 REST OF THE WORLD 181
9.5.1 FLOURISHING BIOTECHNOLOGY & PHARMACEUTICAL MARKETS IN BRAZIL AND MEXICO 181
9.5.2 INCREASING R&D FUNDING IN THE LATIN AMERICAN REGION 181
9.5.3 HIGH PREVALENCE OF HIV IN AFRICAN REGION IS LIKELY TO OPEN NEW GROWTH POTENTIAL FOR THE LAB AUTOMATION, IMMUNOASSAY, AND PCR MARKETS 182
10 COMPETITIVE LANDSCAPE 187
10.1 INTRODUCTION 187
10.1.1 NEW PRODUCT LAUNCHES 189
10.1.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 190
10.1.3 EXPANSIONS 191
10.1.4 ACQUISITIONS 192
10.1.5 OTHER DEVELOPMENTS 193
11 COMPANY PROFILES 195
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 INTRODUCTION 195
11.2 AGILENT TECHNOLOGIES, INC. 196
11.3 BECTON, DICKINSON AND COMPANY 204
11.4 BIO-RAD LABORATORIES, INC. 208
11.5 BRUKER CORPORATION 213
11.6 DANAHER CORPORATION 218
11.7 F. HOFFMANN-LA ROCHE LTD. 224
11.8 PERKINELMER, INC. 228
11.9 SHIMADZU CORPORATION 233
11.10 THERMO FISHER SCIENTIFIC, INC. 239
11.11 WATERS CORPORATION 247
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.
12 APPENDIX 253
12.1 INSIGHTS OF INDUSTRY EXPERTS 253
12.2 DISCUSSION GUIDE 254
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 256
12.4 AVAILABLE CUSTOMIZATIONS 256
12.5 RELATED REPORTS 257
【レポート販売概要】
■ タイトル：ライフサイエンス及び化学分析機器の世界市場：クロマトグラフィー装置、電気泳動、DNAシークエンサー、PCR、マイクロプレートリーダー等■ 英文：Life Science and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, Microplate Reader, Robotics, Spectroscopy, Immunoassay, Microarray, Flow Cytometer, Incubator, Fume Hood, Centrifuge) - Global Forecast to 2019
■ 発行日：2015年3月31日
■ 調査会社：MarketsandMarkets
■ 商品コード：MAM-BT-3282
■ 調査対象地域：グローバル
- キメラ抗原受容体T細胞療法（CART）の世界市場Summary DelveInsight Report, “Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015” emphasizes on the currently active CAR-T cell products in research and development. The Report covers the 35+ companies which are active in this field including 14 leading companies with 35 products targeting 20 different antigens and 9 different techno …
- エンジニアリング・プラスチックの世界市場The engineering plastic market presents huge potential for growth in the coming years. Engineering plastics market is experiencing rapid growth, which is expected to continue in the near future, mainly driven by ability of engineering plastics to replace metals in various end- user industries. They are preferred mainly due to their properties such as high dimensional stability, good strength, high …
- アジアの患者診察機器市場見通し（～2021）Asia-Pacific Patient Examination Devices Market Outlook to 2021 Summary GlobalData’s new report, "Asia-Pacific Patient Examination Devices Market Outlook to 2021", provides key market data on the Asia-Pacific Patient Examination Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Stethoscopes and T …
- 世界のフレーバー（風味）市場2014：主要企業の戦略的分析Complete report $11,700. Individual company assessments $1,450. This report provides insightful analyses of the major competitors in the worldwide flavor market, including their performance, capabilities, goals and strategies. The report contains information not available from any other source, such as sales force estimates by country. The report is designed to provide the flavor industry ex …
- 世界の無人航空機(UAV)市場動向（2012-2016）TechNavio's analysts forecast the Global Unmanned Aerial Vehicle (UAV) market to grow at a CAGR of 3.17 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in UAV launch. The Global Unmanned Aerial Vehicle (UAV) market has also been witnessing an increase in R&D. However, the rapid technological changes could pose a challenge to the growth o …
- 世界主要国における核酸検査市場2015This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative technologies and products. This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portf …
- 遺伝子治療の世界市場分析PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis Summary GlobalData’s "PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis" report is an essential source of information and analysis on the gene therapy field. Using detailed company data, deal analysis, corporate strategy, and market trends analysis, GlobalData provides an in-depth analysis of the current and …
- 石油・ガス産業用分散制御システム（DCS）の世界市場2019-2023Technavio Announces the Publication of its Research Report – Global Distributed Control Systems (DCS) Market in the Oil and Gas Industry 2019-2023 Technavio recognizes the following companies as the key players in the global distributed control systems (DCS) market in the oil and gas: ABB, Emerson Electric Co., Honeywell International Inc., Rockwell Automation, Inc., Schneider Electric, Siemens. C …
- 仙骨神経刺激療法（SNS）の世界市場2017-2021About sacral nerve stimulationSacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor. Technavio’s analysts forecast the global sacral nerve stimulation market to grow at a CAGR of 4.66% during the period 2017-2021. [Cov …
- 外傷(Trauma)の治療薬パイプライン動向（2015年上半期版）Trauma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Trauma - Pipeline Review, H1 2015’, provides an overview of the Trauma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Trauma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (R …
- 子宮内膜アブレーション装置の世界市場2019-2023About this market Growing adoption of endometrial ablation devices to drive market growth. Increasing gynecological disorders such as uterine myomas and endometriosis have led patients to opt for various diagnostic and surgical treatment procedures. Rapid technological advances in the medical devices sector have led to the development and adoption of endometrial ablation devices as treatment care. …
- スマートガラスの世界市場：SPD、エレクトロクロミックガラス、LC/PDLC、マイクロ・ブラインド、ナノ結晶、フォトクロミックガラス、サーモクロミックガラスMarketsandMarkets forecast the global smart glass market to grow from USD 2.38 Billion in 2015 to USD 5.81 Billion by 2020, at a CAGR of 19.5% between 2015 and 2020. The emerging automobile and architectural buildings applications are creating a huge demand for smart glass market across the world. The major factors driving the growth of the smart glass market are the need for energy-efficient solu …
- 世界の高度CO2センサー市場動向（2012-2016）TechNavio's analysts forecast the Global Advanced CO2 Sensors market to grow at a CAGR of 32.5 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for location-specific CO2 sensors. The Global Advanced CO2 Sensors market has also been witnessing the increasing institutional usage of CO2 sensors. However, the high cost of advanced CO …
- 人工リフトポンプの世界市場2016-2020About the Artificial Lift Pumps Market As a direct impact of the ambiguity in the oil market, the global artificial lift pumps market has been experiencing sluggishness in the recent past as it has become enmeshed with the turmoil in the global oil industry. Declining prices, deferred investments, investor skepticism, and an unpredictable future in the commodity's outlook are inhibiting the growth …
- SoI（システムオヴインサイト）の世界市場予測（～2024年）The global system of insight market size to grow at a Compound Annual Growth Rate (CAGR) of 22.2% during the forecast periodThe global system of insight market size is expected to grow from USD 1.2 billion in 2019 to USD 3.4 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 22.2% during the forecast period. The major factors expected to drive the growth of the system of insight market in …
